Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Small Cell Lung Carcinoma 8Neuroblastoma 5Rhabdoid Tumor 3Ovarian Neoplasms 3Neoplasms 3Fallopian Tube Neoplasms 3Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Sarcoma 1SCLC 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Fallopian Tube Mucinous Adenocarcinoma 1Epilepsy 1Diffuse Intrinsic Pontine Glioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

ruxolitinib 9navitoclax 4Tacrolimus 4Cyclophosphamide 4Whole-Body Irradiation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3venetoclax 2fludarabine phosphate 2fludarabine 2Melphalan 2Busulfan 2veliparib 1selinexor 1pevonedistat 1luspatercept 1letermovir 1itacitinib 1imetelstat 1givinostat hydrochloride 1givinostat 1fedratinib 1elotuzumab 1canakinumab 1avelumab 1Valganciclovir 1Topotecan 1Therapeutics 1Stem Cell Transplantation 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Primary Myelofibrosis × Topotecan × Clear all
NCT03289910 2026-04-13

Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
25 enrolled 15 charts
MyeloidOther hematologic neoplasm

Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡